Cargando…

Iron Indices in Patients with Functional Anemia in Chronic Kidney Disease

BACKGROUND: Despite high ferritin level, HDCKD patients may have functional iron deficiency even after intravenous iron (iv) therapy. The aim of this study was to test the hypothesis that lowered serum transferrin level may contribute to functional anemia and erythropoietin hypo responsiveness by th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reddy, G. Chinnapu, Devaki, Ramakrishna, Rao, Pragna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Communications and Publications Division (CPD) of the IFCC 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975187/ https://www.ncbi.nlm.nih.gov/pubmed/27683448

Ejemplares similares

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease
por: Ganz, Tomas, et al.
Publicado: (2023)

Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease
por: Torino, Ana Beatriz Barbosa, et al.
Publicado: (2015)

Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia
por: Mahajan, Gunjan, et al.
Publicado: (2017)

The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease
por: Gao, Zhaoli, et al.
Publicado: (2023)

Evaluation of red cell and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease
por: Torino, Ana Beatriz Barbosa, et al.
Publicado: (2014)

Comment on: Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease()
por: Piva, Elisa
Publicado: (2015)

Predicting hepcidin level using inflammation markers and iron indicators in patients with anemia of chronic disease
por: Suega, Ketut, et al.
Publicado: (2019)

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
por: Larson, Derek S., et al.
Publicado: (2013)

Improving compliance with iron infusion therapy in the treatment of chronic anemia in haemodialysis patients with chronic kidney disease
por: Nuti, Amith
Publicado: (2015)

Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes
por: Conway, Baqiyyah N, et al.
Publicado: (2018)

Efficacy and Mechanism of Roxadustat plus Oral Iron in the Treatment of Elderly Chronic Kidney Disease with Anemia
por: Liu, Bo, et al.
Publicado: (2022)

Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
por: Nagaraju, Shankar P, et al.
Publicado: (2013)

Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease
por: Ueda, Norishi, et al.
Publicado: (2018)

Reticulocyte maturity indices in iron deficiency anemia
por: Wollmann, Muriel, et al.
Publicado: (2014)

Nanoparticles: Is Toxicity a Concern?
por: D, Ramakrishna, et al.
Publicado: (2011)

Is soluble transferrin receptor a good marker of iron deficiency anemia in chronic kidney disease patients?
por: Gupta, S., et al.
Publicado: (2009)

Hemoglobin response to ferric citrate in patients with nondialysis‐dependent chronic kidney disease and iron deficiency anemia
por: Pergola, Pablo E., et al.
Publicado: (2018)

Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease
por: Hirai, Keiji, et al.
Publicado: (2023)

Symptoms and impacts in anemia of chronic kidney disease
por: Mathias, Susan D., et al.
Publicado: (2020)

Desidustat in Anemia due to Dialysis-Dependent Chronic Kidney Disease: A Phase 3 Study (DREAM-D)
por: Gang, Sishir, et al.
Publicado: (2022)

Anemia in children with chronic kidney disease
por: Koshy, Susan M., et al.
Publicado: (2007)

Anemia, Diabetes, and Chronic Kidney Disease
por: Mehdi, Uzma, et al.
Publicado: (2009)

Anemia and mortality in patients with nondialysis-dependent chronic kidney disease
por: Stirnadel-Farrant, Heide A., et al.
Publicado: (2018)

Prevalence of Iron Deficiency Anemia Indicated for Intravenous Iron Treatment in the Korean Population
por: Choi, Rihwa, et al.
Publicado: (2023)

The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans
por: Bielesz, Bernhard, et al.
Publicado: (2020)

Retracted: Efficacy and Mechanism of Roxadustat plus Oral Iron in the Treatment of Elderly Chronic Kidney Disease with Anemia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
por: Gutiérrez, Orlando M.
Publicado: (2021)

Whole-body iron transport and metabolism: Mechanistic, multi-scale model to improve treatment of anemia in chronic kidney disease
por: Sarkar, Joydeep, et al.
Publicado: (2018)

Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia
por: Güneş, Ali, et al.
Publicado: (2015)

Treatment of Anemia of Chronic Disease with True Iron Deficiency in Pregnancy
por: Amstad Bencaiova, Gabriela, et al.
Publicado: (2017)

New options for the anemia of chronic kidney disease
por: Coyne, Daniel W., et al.
Publicado: (2017)

Anemia of Inflammation with An Emphasis on Chronic Kidney Disease
por: Begum, Sajidah, et al.
Publicado: (2019)

Prevalence of Anemia in Chronic Kidney Disease in the United States
por: Stauffer, Melissa E., et al.
Publicado: (2014)

Anemia and risk for cognitive decline in chronic kidney disease
por: Kurella Tamura, Manjula, et al.
Publicado: (2016)

Studying anemia of chronic disease and iron deficiency in patients with rheumatoid arthritis by iron status and circulating hepcidin
por: Khalaf, Warqaa, et al.
Publicado: (2019)

The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease
por: Wu, Chih-Jen, et al.
Publicado: (2017)

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
por: Koury, Mark J., et al.
Publicado: (2022)

Intravenous Iron Dextran as a Component of Anemia Management in Chronic Kidney Disease: A Report of Safety and Efficacy
por: Yessayan, Lenar, et al.
Publicado: (2013)

Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
por: Lee, Keum Hwa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5hodc7i6rieu1ssi0am1l49qi3